[1]
Morales-Buenrostro, L.E., Citlali Juárez-Comboni, S. and Rodríguez Alcocer, A.N. 2017. Renal effects and nephroprotection induced by SGLT2 inhibitor Empagliflozin in patients with Diabetes Mellitus: a literature review. Revista de Nefrología, Diálisis y Trasplante. 37, 1 (Jan. 2017), 48-61.